Comparing activation and recoil forces generated by epinephrine autoinjectors and their training devices - 29/03/12
Doi : 10.1016/j.jaci.2011.10.007
Ryan C. Jacobsen, MD a 
, Trent M. Guess, PhD b, A. Wesley Burks, MD c
, Trent M. Guess, PhD b, A. Wesley Burks, MD c a Department of Emergency Medicine, Truman Medical Center, University of Missouri–Kansas City School of Medicine, Division of Emergency Medical Services, Children’s Mercy Hospitals and Clinics, Kansas City, Mo
b Department of Mechanical Engineering, University of Missouri–Kansas City, Kansas City, Mo
c Division of Pediatric Allergy and Immunology, Duke University Medical Center, Durham, NC
| Supported by a grant from Emergency Physicians Foundation, Kansas City, Mo. |
|
| Disclosure of potential conflict of interest: R. C. Jacobsen receives research support from the Emergency Physicians Foundation. A. W. Burks is a minority stockholder in Allertein and MastCell, Inc; is on the advisory board for Dannon Co Probiotics; has consultant arrangements with Exploramed Development, Intelliject, McNeil Nutritionals, Merck & Co, Novartis, Pfizer, Portola Pharmaceuticals, and Schering-Plough; is on the Expert Panel for Nutricia; receives research support from the National Institutes of Health, the Food Allergy and Anaphylaxis Network, the Food Allergy Initiative, the National Peanut Board, SHS, and the Wallace Research Foundation; has provided legal consultation or expert witness testimony in cases related to food allergy; is on the Medical Board of Directors for the Food Allergy and Anaphylaxis Network; is a Dermatological Allergy Committee Member for the American College of Allergy, Asthma & Immunology; is a member of the National Institutes of Health Hypersensitivity, Autoimmune, and Immune-mediated Diseases Study Section; is a member of the Reviewer Board for the Journal of Allergy and Clinical Immunology; and is member of the food advisory committee for the US Food and Drug Administration. T. M. Guess declares that he has no relevant conflicts of interest. |
© 2011
American Academy of Allergy, Asthma & Immunology. Publié par Elsevier Masson SAS. Tous droits réservés.
Vol 129 - N° 4
P. 1143 - avril 2012 Retour au numéro
Article précédent
- Human TH2 cells respond to cysteinyl leukotrienes through selective expression of cysteinyl leukotriene receptor 1
- Celine N. Parmentier, Elisabeth Fuerst, Joanne McDonald, Holly Bowen, Tak H. Lee, James E. Pease, Grzegorz Woszczek, David J. Cousins
- Predetermined challenge eligibility and cessation criteria for oral food challenges in the HealthNuts population-based study of infants
- Jennifer J. Koplin, Mimi L.K. Tang, Pamela E. Martin, Nicholas J. Osborne, Adrian J. Lowe, Anne-Louise Ponsonby, Marnie N. Robinson, Dean Tey, Leone Thiele, David J. Hill, Lyle C. Gurrin, Melissa Wake, Shyamali C. Dharmage, Katrina J. Allen, HealthNuts investigators
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?